Barnaby joined Aroa Biosurgery’s management team over 12 years ago. Barnaby has over 15 years’ experience in medical device development and commercialisation. Prior to joining Aroa Biosurgery, Barnaby was Scientific Director for InPro Biotechnology (San Francisco, California) and Adjunct Professor, University of California San Francisco (UCSF). Barnaby has extensive research experience in the fields of regenerative medicine and medicinal chemistry, targeting diseases such as HIV, Alzheimer’s, CJD and the neglected tropical diseases. Barnaby is well published with over 35 peer-reviewed publications, numerous international patents and book chapters. During his time at Aroa Biosurgery, Barnaby has lead product and process development and clinical activities. Dr. May has a PhD (Canterbury University, New Zealand) in Medicinal Chemistry and undertook post-doctoral research at the University of California San Francisco.